Down early in the day, the FTSE Eurofirst 300 managed to recover to close 0.9 percent higher to 1,355.41 on a slow day when some European markets were closed for the Assumption Day holiday.

Stocks in technology sectors benefited from comments issued by Morgan Stanley. Among software companies, SAP added 2.7 percent to €143.08. STMicroelectronics was 4.1 percent higher to €12.29, while in the telecommunications equipment sector Ericsson gained 4.2 percent to SKr22.60.

The pharmaceuticals sector was up on the day. Novartis was up by 1 percent to SFr69.95 even though its Sandoz generics division could be a target of a lawsuit by Sanofi-Aventis over unauthorized manufacture of generic copies of Plavix. The gain for Novartis came on a reconfirmation of Dresdner Kleinwort’s “buy” recommendation. Sanofi was also up, adding 2.5 percent to €70.30.

Among banks, UBS was 3.4 percent higher to SFr68.30 on a second quarter report that showed a 47 percent gain in net profits, well above what had been expected.

In the chemicals sector, Akzo Nobel added 4 percent to €44.35 on the news that it will ask shareholders to approve a spinoff of its pharmaceuticals unit and to make 30 percent of the new company available on Euronext in 2007.

In Europe on Tuesday the FTSE Eurofirst 300 gained 0.2 percent to 1,347.58, with the telecommunications and pharmaceuticals sectors helping out substantially. Utilities were also up.

Spanish utility Endsea released its first-quarter report, showing core profits that were up 31 percent. Growth in Europe and Latin America was credited with the improvement, sending shares in Endsea up 1 percent on the day to €26.55. Gas Natural and Eon, both interested in acquiring Endsea, were up 0.3 percent to €213.96 and 0.4 percent to €89.95 respectively.

Among pharmaceuticals companies, Sanofi-Aventis added 2.8 percent to €75.70. Roche and Novartis were each up by 2.2 percent, with Roche at SFr214.60 and Novartis at SFr69.50. The gains for Novartis came on news that tests in the United States have shown that its drug Exelon is helpful in treating dementia related to Parkinson’s disease.

It was the second day in a row for gains in the telecommunications sector. Hellenic Telecom was the biggest gain in the sector, adding 3.5 percent to €18.60. It is expected to bid for the shares of Mobi63 owned by the government of Serbia when those shares are auctioned in July. Deutsche Telekom, also likely to bid on the shares, was up 0.5 percent to €13.05. Elsewhere in fixed-line telecoms, Swisscom was up 1.3 percent to SFr405, while France Telecom rose by 1.5 percent to €17.49 on an upwardly revised revenue forecast from Bear Stearns.

Mobile telecoms also saw gains. Telnor gained 2.9 percent to NKr80.75, while Cosmote added 2.6 percent to €19.68.

In the oil sector, OMV of Austria dropped 5.7 percent to €45.13 despite a 24 percent rise in first-quarter profits when lower refining margins kept profits below levels that had been predicted.

In Europe on Friday, the FTSE Eurofirst 300 was up 0.5 percent to 1,383.19. The day’s gain helped the Eurofirst to add 1 percent on the week.

In the pharmaceuticals sector, Schering was up 4.6 percent on the week to €86.30 on an offer from Bayer that was higher than an earlier bid from Merck, which withdrew its bid on the grounds that it could not justify upping its offer. Even though WestLB issued a downgrade on Bayer from “add” to “hold” because it considered the possible deal “ambitious”, Bayer still added 6.8 percent on the week to €35.42. Merck, meanwhile, gained 1.4 percent to €80.99 on a reiteration of WestLB’s “buy” recommendation. Elsewhere in the sector, Sanofi-Aventis was up by 5.2 percent to €77.45 on news that a patent dispute had been settled.

In the automobile manufacturing sector, Volkswagen gained 6.7 percent to €62.13, while Fiat was up 7.6 percent to €10.01. BMW added 8.8 percent to €46.01 on indications that it will do well this year.

French telecom equipment maker Alcatel gained 1.6 percent to €13.05 on Friday, a two-year high, bringing its advance for the week to 8.9 percent. The gains came on news that it had re-entered merger talks with US company Lucent Technologies. Rumors that a merger would prompt Alcatel to sell its 9.5 percent stake in defense group Thales. This sent shares in Thales up 4.5 percent on Friday, to €37.65.

Mergers and acquisitions again took center stage as European equities markets dropped on Wednesday, with the FTSE Eurofirst 300 down to its lowest close in three weeks, dropping 0.8 percent to 1,333.17.

Utilities were still in the midst of a round of bids and counter bids. The board of Enel met to consider how to react to a planned merger between Suez and Gaz de France, including mulling a possible bid for Suez. Suez gained 3.2 percent on the day to €34.07, while Enel lost 0.7 percent to €6.853 and Gaz de France dropped 0.4 percent to €29.29.

Elsewhere, Dutch media group VNU agreed to be purchased by a group of private equity firms, although one asset management company holding around 2 percent of VNU’s shares said it would reject the bid and asked VNU’s board to let shareholders vote on a new sale process. Other shareholders were unlikely to support the request. VNU closed slightly lower at €28.75.

In the pharmaceuticals sector, up 1.8 percent as a whole, Sanofi-Aventis and Novartis were both higher after Morgan Stanley called stocks in the sector “very cheap”. Sanofi was up 2.5 percent to €72.65, while Novartis advanced by 1.1 percent to €71.35.

Hotel group Accor, meanwhile, dropped 7.4 percent to €47.47 after investors were disappointed by a reduced dividend and no clear guidance to where the company is headed.

European equities markets were up in mid-afternoon trade on Friday, with the FTSE Eurofirst up 0.2 percent to 1,358.08. Additionally, Germany’s Xetra Dax was up 0.1 percent to 5,861.5 and the CAC 40 in Paris gained 0.4 perent to 5,062.2

Companies related to food production and sales were mixed on the day. Danone was up 2 percent to €96.95 on an upgrade from “equalweight” to “overweight” from Morgan Stanley coupled with a new share price target of €108. Earnings growth for the company was predicted to reach the mid-teens in the next two years. Food retailer Ahold, the fourth largest in the world, was also up, by 1.3 percent to €6.99 as it said it is thinking of making significant acquisitions for the first time since it nearly went bankrupt three years ago. Numico, however, lost 3.1 percent to €35.99 on a downgrade to “in-line” by Goldman Sachs on the basis of its cautious outlook statement.

In the related brewing sector, Inbev was down 3.1 percent to €36.54 despite full year earnings reports which showed operating profits coming in slightly above predictions at €3.33 billion, with growth at 15.3 percent.

The utilities sector was still seeing bid rumours. Endsea, a bid target for Eon, was up 0.6 percent to €26.24. In new rumors, Gaz de France and Suez are said to be thinking of forming an alliance to repel a bid for Suez by Enel of Italy. Gaz de France gained 2.6 percent to €29.35 and Suez was up 4.1 percent to €33.32, while Enel dropped 0.7 percent to €7.12.

In the pharmaceuticals sector, Sanofi Aventis gained 0.5 percent to €72.45 despite announcing that the launch of its anti-obesity treatement in the United States could be put off until later in the year. The drug company’s full-year report showed that net profits were up by 25.7 percent to €6.34 billion, and it said that its earnings should grow by about 10 percent this year.

Equities markets in Europe saw advances on Monday on the strength of gains the oil sector as the FTSE Eurofirst gained 0.2 percent to 1,345.92, a new four and a half year high.

The oil sector was up on higher crude oil prices. Statoil gained 3.5 percent to €178. Meanwhile Saipem, the largest oil field services company in Europe, was up 3.1 percent to €16.04.

The banking sector was also up, with more takeover talk in Italian banking. Mediobanca, rumored to be a target despite an agreement that gives core shareholders 54 percent of the bank, was up 4.2 percent to a record high share prices of €17.60. Capitalia, also seen as a potential takeover target, gained 2.8 percent to €6.325. Meanwhile, EFG Eurobank was up 4 percent to €33.06 as JP Morgan raised its price target from €40 to €44 on the strength of the bank’s expansion in southeastern and central Europe.

Utilities were up on the day as well, with Electricite de France gaining 2.2 percent to €41.56 on consolidation talk. Eon gained 0.6 percent to €93.44 after its chief executive said he expects that three dominant players will emerge in the sector.

The pharmaceuticals sector was mixed. Schering was up 3.3 percent to €58.39 on an announcement that its fourth-quarter operating profits were up 30 percent, slightly higher than forecasts. It also said that it will buy the property and equipment used by its US partner, Chiron, to produce the drug Betaferon (Betaseron in the US), which is expected to be approved for the treatment of early-stage multiple sclerosis before the end of the third quarter. Shares in Novartis, which has not yet finalized its planned purchase of Chiron, was up 0.1 percent to SFr71.50.

Elsewhere in the sector, Serono dropped 2.2 percent to SFr959 as concern grew about competition between its multiple sclerosis drug Rebif with Betaferon. Sanofi-Aventis dropped 3 percent to €71.70 after regulators in the United States delayed final approval of Acomplia as a weight management treatment and rejected the drug as a stop-smoking aid.